Pennington Biomedical Research Center researchers are gearing up and preparing to head to San Antonio for ObesityWeek 2024, presented by The Obesity ...
News
- Pennington Biomedical to be on display at ObesityWeek 2024 in San Antonio - EurekAlert!
- ALX Oncology Announces Results From Phase 1b/2 Trial Of Evorpacept In Combination ...
... biotechnology company advancing therapies that boost the immune ... San Antonio Breast Cancer Symposium (SABCS), which will be held in San ...
- ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with ...
... biotechnology company advancing therapies that boost the immune syste. ... San Antonio Breast Cancer Symposium (SABCS), which will be held in San ...
- ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with ...
... San Antonio Breast Cancer Symposium (SABCS), which will be held in San ... Biotechnology & Medical Research. Calendar. 2024-11-12 - Q3 2024 ...
- Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and ...
... San Antonio Breast Cancer Symposium (SABCS) taking place December 10-13 ... Harnessing the power of biotechnology, chemistry and genetic ...